ArticleBMC nephrology2025
Comparative evaluation of cystatin C- and creatinine-based equations for estimating glomerular filtration rate in children with cerebral palsy and healthy controls in a Nigerian tertiary hospital.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveChildren with cerebral palsy (CP) often experience various medical and functional challenges that may impact renal function over time. Despite this risk, routine renal evaluations and nephrology referrals are not commonly part of their standard care protocol. This study aimed to compare cystatin C- and creatinine-based estimated glomerular filtration rates (eGFR) between children with cerebral palsy and healthy controls. METHODOLOGY: A hospital-based, cross-sectional comparative study was conducted at the Paediatric Neurology and Nephrology Clinicsand general children’s outpatient clinic of Nnamdi Azikiwe University Teaching Hospital (NAUTH), Nnewi. A total of 100 children aged 5–18 years comprising 50 children with cerebral palsy and 50 age- and sex-matched healthy controls, were enrolled. Relevant sociodemographic and clinical data were collected using a structured questionnaire. Blood samples were analyzed for serum creatinine and cystatin C. eGFR was calculated using the Modified Schwartz formula (for creatinine) and the univariate cystatin C formula. Data were analyzed using SPSS version 26.
resultsThe mean serum creatinine level was significantly lower in children with CP (0.596 ± 0.117 mg/dL) compared to controls (0.702 ± 0.123 mg/dL; p < 0.001). Consequently, creatinine-based eGFR was significantly higher in the CP group (95.99 ± 18.91 mL/min/1.73 m²) than in controls (88.55 ± 15.44 mL/min/1.73 m²; p = 0.043). However, there were no significant differences in mean cystatin C levels (0.682 ± 0.096 mg/L vs. 0.686 ± 0.073 mg/L; p = 0.852) or cystatin C-based eGFR (102.12 ± 9.52 mL/min/1.73 m² vs. 101.34 ± 8.86 mL/min/1.73 m²; p = 0.671) between the groups.
conclusionMost children with cerebral palsy demonstrated eGFR values within normal ranges using both creatinine and cystatin C markers. Furthermore, creatinine-based eGFR was higher in children with cerebral palsy compared to healthy controls, likely reflecting reduced muscle mass rather than superior renal function. Cystatin C may be a more reliable marker for renal function assessment in children with cerebral palsy, as it is less influenced by muscle mass variations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.